Sana Biotechnology annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Sana Biotechnology Depreciation & Amortization Growth & History (SANA)
Sana Biotechnology's depreciation and amortization was $12.8M for fiscal 2025.
View full Sana Biotechnology company overviewSana Biotechnology annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.8M | −$2.7M | −17.42% |
| 2024 | 2024-12-31 | $15.5M | −$2.0M | −11.43% |
| 2023 | 2023-12-31 | $17.5M | $1.9M | +12.18% |
| 2022 | 2022-12-31 | $15.6M | $4.5M | +40.54% |
| 2021 | 2021-12-31 | $11.1M | $5.2M | +87.47% |
| 2020 | 2020-12-31 | $5.9M | $4.1M | +224.26% |
| 2019 | 2019-12-31 | $1.8M | — | — |
Sana Biotechnology quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.2M | −$700,000 | −24.14% |
| Q1 2026 | 2026-03-31 | $2.4M | −$1.3M | −34.48% |
| Q4 2025 | 2025-12-31 | $3.1M | — | — |
| Q3 2025 | 2025-09-30 | $3.2M | −$900,000 | −21.95% |
| Q2 2025 | 2025-06-30 | $2.9M | −$1.0M | −25.64% |
| Q1 2025 | 2025-03-31 | $3.6M | −$97,000 | −2.59% |
| Q3 2024 | 2024-09-30 | $4.1M | −$400,000 | −8.89% |
| Q2 2024 | 2024-06-30 | $3.9M | −$600,000 | −13.33% |
| Q1 2024 | 2024-03-31 | $3.7M | −$554,000 | −12.88% |
| Q3 2023 | 2023-09-30 | $4.5M | $500,000 | +12.50% |
| Q2 2023 | 2023-06-30 | $4.5M | $700,000 | +18.42% |
| Q1 2023 | 2023-03-31 | $4.3M | $686,000 | +18.98% |
| Q3 2022 | 2022-09-30 | $4.0M | $1.2M | +42.86% |
| Q2 2022 | 2022-06-30 | $3.8M | $1.2M | +46.15% |
| Q1 2022 | 2022-03-31 | $3.6M | $1.4M | +60.84% |
| Q3 2021 | 2021-09-30 | $2.8M | $1.2M | +75.00% |
| Q2 2021 | 2021-06-30 | $2.6M | $1.2M | +85.71% |
| Q1 2021 | 2021-03-31 | $2.2M | $982,000 | +77.63% |
| Q3 2020 | 2020-09-30 | $1.6M | — | — |
| Q2 2020 | 2020-06-30 | $1.4M | — | — |
| Q1 2020 | 2020-03-31 | $1.3M | — | — |
Sana Biotechnology depreciation and amortization trends
Over the last five fiscal years, Sana Biotechnology's depreciation and amortization increased from $5.9M to $12.8M, a change of $6.9M. The latest reported quarter, Q2 2026, shows $2.2M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sana Biotechnology source filings ↗